1. 1463: EFFICACY OF HIGH AND LOW DOSES OF NOVEL PSC-INDUCED MESENCHYMAL STROMAL CELLS IN OVINE ARDS. (16th December 2021) Authors: Homma, Kento; Hashimoto, Kazuki; Bazhanov, Nikolay; Angel, Matt; Lader, Alan; Czuczman, Myron; Matthay, Michael; Enkhbaatar, Perenlei Journal: Critical care medicine Issue: Volume 50(2022)Supplement 1 Page Start: 734 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1463: EFFICACY OF HIGH AND LOW DOSES OF NOVEL PSC-INDUCED MESENCHYMAL STROMAL CELLS IN OVINE ARDS. (January 2022) Authors: Homma, Kento; Hashimoto, Kazuki; Bazhanov, Nikolay; Angel, Matt; Lader, Alan; Czuczman, Myron; Matthay, Michael; Enkhbaatar, Perenlei Journal: Critical care medicine Issue: Volume 50(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Durvalumab as monotherapy and in combination therapy in patients with lymphoma or chronic lymphocytic leukemia: The FUSION NHL 001 trial. Issue 1 (19th July 2022) Authors: Casulo, Carla; Santoro, Armando; Cartron, Guillaume; Ando, Kiyoshi; Munoz, Javier; Le Gouill, Steven; Izutsu, Koji; Rule, Simon; Lugtenburg, Pieternella; Ruan, Jia; Arcaini, Luca; Casadebaig, Marie‐Laure; Fox, Brian; Kilavuz, Nurgul; Rettby, Nils; Dell'Aringa, Justine; Taningco, Lilia; Delarue, R... Journal: Cancer reports Issue: Volume 6:Issue 1(2023) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma. Issue 12 (20th April 2021) Authors: Nowakowski, Grzegorz S.; Chiappella, Annalisa; Gascoyne, Randy D.; Scott, David W.; Zhang, Qingyuan; Jurczak, Wojciech; Özcan, Muhit; Hong, Xiaonan; Zhu, Jun; Jin, Jie; Belada, David; Bergua, Juan Miguel; Piazza, Francesco; Mócikova, Heidi; Molinari, Anna Lia; Yoon, Dok Hyun; Cavallo, Federica; T... Journal: Journal of clinical oncology Issue: Volume 39:Issue 12(2021) Page Start: 1317 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study. Issue 6 (June 2015) Authors: Palanca-Wessels, Maria Corinna A; Czuczman, Myron; Salles, Gilles; Assouline, Sarit; Sehn, Laurie H; Flinn, Ian; Patel, Manish R; Sangha, Randeep; Hagenbeek, Anton; Advani, Ranjana; Tilly, Herve; Casasnovas, Olivier; Press, Oliver W; Yalamanchili, Sreeni; Kahn, Robert; Dere, Randall C; Lu, Dan; J... Journal: Lancet oncology Issue: Volume 16:Issue 6(2015:Jun.) Page Start: 704 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials. (21st December 2018) Authors: Lansigan, Frederick; Barak, Ian; Pitcher, Brandelyn; Jung, Sin‐Ho; Cheson, Bruce D.; Czuczman, Myron; Martin, Peter; Hsi, Eric; Schöder, Heiko; Smith, Scott; Bartlett, Nancy L.; Leonard, John P.; Blum, Kristie A. Journal: Cancer medicine Issue: Volume 8:Number 1(2019:Jan.) Page Start: 165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗